Hemispherx Biopharma, Inc.
Exhibit 10.1
Hemispherx Biopharma, Inc.
0000 XX Xxxxxxx 000
Xxxxx, XX 00000
July 17, 2019 |
Maxim Group LLC
000 Xxxxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Re: Termination of Equity Distribution Agreement by and between Hemispherx Biopharma, Inc. (the “Company”) and Maxim Group LLC (“Maxim”) dated July 23, 2012, as subsequently amended (the “EDA”)
Dear Sir or Madam:
Pursuant to our discussions we have agreed to terminate the EDA. Accordingly, pursuant to Section 7(a) of the EDA, the Company hereby terminates the EDA, effective as of the close of business today, July 17, 2019.
Sincerely, | |
/s/ Xxxxxx X. Xxxxxx | |
Xxxxxx X. Xxxxxx, CEO |